FDA to Hold Public Hearing on Cannabis
The Food and Drug Administration (FDA) announced that it will hold a public hearing to collect information related to the safety, production, and sale of cannabis products. The hearing is scheduled for May 31, 2019. The goal of the hearing conducted by the FDA is to provide information to the regulatory oversight committee about the safety of cannabis in FDA regulated products. The FDA has additionally announced its plan to form a committee to assess the process for lawfully marketing dietary supplements and food products containing cannabidiol (CBD). Safety concerns regarding cannabis have increased as the use of cannabis products…